Lawyers see the prospect for thousands of suits after contaminants turned up in the widely prescribed drugs.

Published on Bloomberg.com on April 24, 2019, 12:01 AM EDT Corrected April 24, 2019, 6:09 PM EDT

Dozens of lawsuits have been filed against drug makers and sellers over widely prescribed generic heart drugs tainted with potential carcinogens, the first claims in what some lawyers expect to be a wave of litigation.

Millions of Americans have taken the drugs, which are at the center of a widening recall being overseen by the U.S. Food and Drug Administration, and have been for decades used to treat high blood pressure, heart failure and other common conditions.

Read the full article on Bloomberg.com >>